Although some reports suggest that intraductal histology may be common in patients with germline BRCA2 mutations [55,56], no tumor features have been strongly associated with the presence of BRCA mutations in prostate cancer beyond a Gleason score >8 and a higher prevalence of node and distant metastasis at diagnosis [8]. The gene discussed is BRCA2; the disease is Familial prostate cancer.